Wolverine Trading, LLC Exelixis, Inc. Put Options Transaction History

Wolverine Trading, LLC

$93.9 Billion
Q3 2024

Put Options

25 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$21.96 - $27.6 $1.16 Million - $1.46 Million	52,900 Added 132.91%	92,700 $2.41 Million
Q2 2024 Aug 14, 2024	BUY	$20.34 - $23.73 $262,386 - $306,117	12,900 Added 47.96%	39,800 $894,000
Q1 2024 May 15, 2024	SELL	$20.17 - $23.93 $280,363 - $332,627	-13,900 Reduced 34.07%	26,900 $638,000
Q4 2023 Feb 14, 2024	BUY	$19.25 - $24.13 $785,400 - $984,504	40,800 New	40,800 $978,000
Q2 2023 Aug 23, 2023	BUY	$18.17 - $20.48 $228,942 - $258,048	12,600 Added 116.67%	23,400 $447,000
Q1 2023 May 15, 2023	BUY	$16.3 - $19.41 $176,040 - $209,628	10,800 New	10,800 $203,000
Q3 2022 Nov 14, 2022	BUY	$15.68 - $22.27 $250,880 - $356,320	16,000 New	16,000 $253,000
Q1 2022 May 16, 2022	SELL	$17.03 - $22.67 $192,439 - $256,171	-11,300 Reduced 40.79%	16,400 $368,000
Q4 2021 Feb 14, 2022	BUY	$15.84 - $21.88 $82,368 - $113,776	5,200 Added 23.11%	27,700 $516,000
Q3 2021 Nov 12, 2021	BUY	$16.3 - $21.14 $27,710 - $35,938	1,700 Added 8.17%	22,500 $464,000
Q2 2021 Aug 06, 2021	BUY	$17.95 - $25.56 $177,705 - $253,044	9,900 Added 90.83%	20,800 $373,000
Q1 2021 May 14, 2021	SELL	$20.53 - $25.22 $383,911 - $471,614	-18,700 Reduced 63.18%	10,900 $239,000
Q4 2020 Feb 12, 2021	SELL	$18.39 - $24.8 $128,730 - $173,600	-7,000 Reduced 19.13%	29,600 $598,000
Q3 2020 Nov 13, 2020	SELL	$20.67 - $26.94 $140,556 - $183,192	-6,800 Reduced 15.67%	36,600 $897,000
Q2 2020 Aug 13, 2020	BUY	$16.46 - $27.42 $57,610 - $95,970	3,500 Added 8.77%	43,400 $986,000
Q1 2020 May 11, 2020	SELL	$14.46 - $21.8 $75,192 - $113,360	-5,200 Reduced 11.53%	39,900 $709,000
Q4 2019 Feb 12, 2020	SELL	$15.15 - $18.89 $372,690 - $464,694	-24,600 Reduced 35.29%	45,100 $799,000
Q3 2019 Nov 14, 2019	SELL	$17.68 - $22.65 $427,856 - $548,130	-24,200 Reduced 25.77%	69,700 $1.25 Million
Q2 2019 Aug 20, 2019	BUY	$18.93 - $24.75 $1.06 Million - $1.38 Million	55,900 Added 147.11%	93,900 $2.01 Million
Q1 2019 May 15, 2019	SELL	$19.6 - $24.76 $209,720 - $264,932	-10,700 Reduced 21.97%	38,000 $904,000
Q4 2018 Feb 14, 2019	SELL	$13.65 - $21.8 $4,095 - $6,540	-300 Reduced 0.61%	48,700 $947,000
Q3 2018 Nov 14, 2018	SELL	$15.87 - $22.4 $39,675 - $56,000	-2,500 Reduced 4.85%	49,000 $868,000
Q1 2018 May 15, 2018	SELL	$22.15 - $31.89 $354,400 - $510,240	-16,000 Reduced 23.7%	51,500 $1.14 Million
Q4 2017 Feb 14, 2018	BUY	$24.23 - $30.93 $162,341 - $207,231	6,700 Added 11.02%	67,500 $2.05 Million
Q3 2017 Nov 15, 2017	BUY	$23.35 - $29.24 $1.42 Million - $1.78 Million	60,800	60,800 $1.47 Million

Others Institutions Holding EXEL

# of Institutions

503

Shares Held

244M

Call Options Held

2.54M

Put Options Held

2.29M

Black Rock Inc. New York, NY

33.5M
Shares

$1.22 Billion
0.02% of portfolio
Vanguard Group Inc Valley Forge, PA

29.3M
Shares

$1.07 Billion
0.01% of portfolio
Farallon Capital Management LLC San Francisco, CA

25.4M
Shares

$926 Million
3.31% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

15.4M
Shares

$560 Million
0.63% of portfolio
State Street Corp Boston, MA

11.4M
Shares

$417 Million
0.01% of portfolio

View Full List

About EXELIXIS, INC.

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $11.7B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

More about EXEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.

Account